Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:2013:424695.
doi: 10.1155/2013/424695. Epub 2013 Jan 2.

Significance of Haemodynamic and Haemostatic Factors in the Course of Different Manifestations of Cerebral Small Vessel Disease: The SHEF-CSVD Study-Study Rationale and Protocol

Affiliations

Significance of Haemodynamic and Haemostatic Factors in the Course of Different Manifestations of Cerebral Small Vessel Disease: The SHEF-CSVD Study-Study Rationale and Protocol

Jacek Staszewski et al. Neurosci J. 2013.

Abstract

Rationale. This paper describes the rationale and design of the SHEF-CSVD Study, which aims to determine the long-term clinical and radiological course of cerebral small vessel disease (CSVD) and to evaluate haemostatic and haemodynamic prognostic factors of the condition. Design. This single-centre, prospective, non-interventional cohort study will follow 150 consecutive patients with different clinical manifestations of CSVD (lacunar ischaemic stroke, vascular dementia, vascular parkinsonism or spontaneous deep, intracerebral haemorrhage) and 50 age- and sex-matched controls over a period of 24 months. The clinical and radiological course will be evaluated basing on a detailed neurological, neuropsychological and MRI examinations. Haemodynamic (cerebral vasoreactivity, 24 h blood pressure control) and haemostatic factors (markers of endothelial and platelet dysfunction, brachial artery flow-mediated dilatation test) will be determined. Discussion. The scheduled study will specifically address the issue of haemodynamic and haemostatic prognostic factors and their course over time in various clinical manifestations of CSVD. The findings may aid the development of prophylactic strategies and individualised treatment plans, which are critical during the early stages of the disease.

PubMed Disclaimer

References

    1. Prins N. D., Van Dijk E. J., Den Heijer T., et al. Cerebral white matter lesions and the risk of dementia. Archives of Neurology. 2004;61(10):1531–1534. doi: 10.1001/archneur.61.10.1531. - DOI - PubMed
    1. Baezner H., Blahak C., Poggesi A., et al. Association of gait and balance disorders with age-related white matter changes: the LADIS Study. Neurology. 2008;70(12):935–942. doi: 10.1212/01.wnl.0000305959.46197.e6. - DOI - PubMed
    1. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. The Lancet Neurology. 2010;9(7):689–701. doi: 10.1016/S1474-4422(10)70104-6. - DOI - PubMed
    1. Vogels R. L. C., Flier W. M., HartenB, et al. Brain magnetic resonance imaging abnormalities inpatients with heart failure. European Journal of Heart Failure. 2007;9:1003–1009. doi: 10.1016/j.ejheart.2007.07.006. - DOI - PubMed
    1. Rouhl R. P. W., Damoiseaux C J. G. M., Lodder J., et al. Vascular inflammation in cerebral small vessel disease. Neurobiology of Aging. 33(8):1800–1806. doi: 10.1016/j.neurobiolaging.2011.04.008. - DOI - PubMed

LinkOut - more resources